Treatment of adenocarcinoma of the endometrium.
The evidence concerning those factors related to prognosis in endometrial carcinoma has been reviewed and age, histologic differentiation of the tumor, depth of myometrial invasion and extent of disease have been found to be definitely correlated with survival. The development of different treatment methods has been traced and various modern treatment techniques have been discussed. On the basis of these prognostic indicators and reported experience with alternative methods of therapy, a plan of management for patients with endometrial carcinoma has been proposed. Although we believe this is a logical method with proven effectiveness, we wish to emphasize the importance of individualized therapy based on an understanding of the clinical-pathological findings.
D000230:Adenocarcinoma / Q000473:pathology / Q000532:radiotherapy / Q000628:therapy*; D000328:Adult; D000367:Age Factors; D000368:Aged; D005260:Female; D006801:Humans; D006908:Hydroxyprogesterones / Q000627:therapeutic use; D007044:Hysterectomy; D008207:Lymphatic Metastasis; D008875:Middle Aged; D009362:Neoplasm Metastasis; D011300:Preoperative Care; D011379:Prognosis; D014594:Uterine Neoplasms / Q000473:pathology / Q000532:radiotherapy / Q000628:therapy*; D014599:Uterus / Q000033:anatomy & histology
D006908:Hydroxyprogesterones